Clinical trialNCT02258542CompletedPhase 3Interventional

A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA

SponsorAstraZenecaEnrollment2,133Asthma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

William W. Busse, M.D., Professor of Medicine
Allergy, Pulmonary, and Critical Care Medicine 600 Highland Avenue; Madison, WI
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

429 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Argentina

Research Site
Buenos Aires, Argentina
Research Site
Buenos Aires, Argentina
Research Site
CABA, Argentina
Research Site
CABA, Argentina
Research Site
CABA, Argentina
Research Site
Ciudad Autónoma de Bs. As., Argentina
Research Site
Concepción del Uruguay, Argentina
Research Site
Corrientes, Argentina
Research Site
Córdoba, Argentina
Research Site
Florida, Argentina
Research Site
Godoy Cruz, Argentina
Research Site
La Plata, Argentina
Research Site
Mar del Plata, Argentina
Research Site
Mendoza, Argentina
Research Site
Mendoza, Argentina
Research Site
Nueve de Julio, Argentina
Research Site
Ranelagh, Argentina
Research Site
Rosario, Argentina
Research Site
San Miguel de Tucumán, Argentina

Australia

Research Site
Bedford Park, Australia
Research Site
Box Hill, Australia
Research Site
Clayton, Australia
Research Site
Concord, Australia
Research Site
Frankston, Australia
Research Site
Nedlands, Australia
Research Site
New Lambton Heights, Australia
Research Site
Parkville, Australia
Research Site
Prahran, Australia
Research Site
Randwick, Australia
Research Site
Woolloongabba, Australia

Brazil

Research Site
Porto Alegre, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Santo André, Brazil
Research Site
Sorocaba, Brazil
Research Site
São Paulo, Brazil
Research Site
São Paulo, Brazil

Bulgaria

Research Site
Dupnitsa, Bulgaria
Research Site
Pazardzhik, Bulgaria
Research Site
Pernik, Bulgaria

389 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Nov 2014
Primary completion: 18 Oct 2017
Completion: 2 Jul 2018
Last update posted: 21 Aug 2019
Registered enrollment: 2,133
Registry id: NCT02258542

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.